Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities.
Yun JI, Yang EH, Latif M, Lee HJ, Lee K, Yun CS, Park CH, Lee CO, Chae CH, Cho SY, Jung HJ, Kim P, Choi SU, Kim HR.
Yun JI, et al. Among authors: chae ch.
Arch Pharm Res. 2014 Jul;37(7):873-81. doi: 10.1007/s12272-013-0247-7. Epub 2013 Oct 16.
Arch Pharm Res. 2014.
PMID: 24129617